Evidence map›Paper›PMID 35096625›Full record

ArticleFrontiers in oncology2021

Pattern of Time-to-Surgery in Patients With Breast Cancer at Different Stages of the COVID-19 Pandemic.

Ruixian Chen, Jiqiao Yang, Xin Zhao, Zhoukai Fu, Zhu Wang, Changjian Qiu, Yunhao Wu, Ruoning Yang, Weijing Liu, Ya Huang and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruixian ChenDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Jiqiao YangDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xin ZhaoDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zhoukai FuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Zhu WangLaboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, China.
Changjian QiuMental Health Center, West China Hospital, Sichuan University, Chengdu, China.
Yunhao WuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Ruoning YangDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Weijing LiuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Ya HuangDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.
Jie ChenDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe management of cancer surgeries is under unprecedented challenges during the COVID-19 pandemic, and the breast cancer patients may face a time-delay in the treatment. This retrospective study aimed to present the pattern of time-to-surgery (TTS) and analyze the features of breast cancer patients under the different stages of the COVID-19 pandemic.

methodsPatients who received surgeries for breast cancers at West China Hospital between February 15, 2020 and April 30, 2020 (the outbreak and post-peak stages), and between March 10, 2021 and May 25, 2021 (the normalization stage) were included. TTS was calculated as the time interval between the pathological diagnosis and surgical treatment of breast cancer patients. And the pandemic was divided into three stages based on the time when the patients were pathologically diagnosed and the severity of pandemic at that time point. TTS, demographic and clinicopathological features were collected from medical records.

resultsA total of 367 patients were included. As for demographic features, it demonstrated statistically significant differences in insurance type (

conclusionsTTS of breast cancer patients significantly varied in different stages of the COVID-19 pandemic. And breast cancer patients' daily lives and disease treatments were affected by the pandemic in many aspects, such as health insurance access, physical screening and change of therapeutic schedules. As the time-delay may cause negative influences on patients' disease, we should minimize the occurrence of such time-delay. It is vital to come up with comprehensive measures to deal with unexpected situations in case the pandemic occurs.

Indexed as

breast cancerCOVID-19pandemicsurgical delayssurgical oncologytime-to-surgery

Identifiers

PMID35096625
PMCPMC8790243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.